[
    [
        {
            "time": "",
            "original_text": "明星基金扎堆重仓股：大举增持+超跌滞涨股仅6只",
            "features": {
                "keywords": [
                    "明星基金",
                    "重仓股",
                    "大举增持",
                    "超跌滞涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "明星基金扎堆重仓股：大举增持+超跌滞涨股仅6只",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "药明康德今日大宗交易成交14.90万股，成交价169.2元溢价0.0%",
            "features": {
                "keywords": [
                    "药明康德",
                    "大宗交易",
                    "成交价",
                    "溢价"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明康德今日大宗交易成交14.90万股，成交价169.2元溢价0.0%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "上市公司纷纷自投“搞私募”！宁德时代、药明康德等十多家纷纷出手，未来是“躺赢”还是“躺平”？",
            "features": {
                "keywords": [
                    "上市公司",
                    "私募",
                    "宁德时代",
                    "药明康德"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市公司纷纷自投“搞私募”！宁德时代、药明康德等十多家纷纷出手，未来是“躺赢”还是“躺平”？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "药明康德(603259)：王者出击 谁与争锋",
            "features": {
                "keywords": [
                    "药明康德",
                    "王者出击"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259)：王者出击 谁与争锋",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "明星基金扎堆重仓股曝光，十年十倍股集中营，大举增持+超跌滞涨股仅6只",
            "features": {
                "keywords": [
                    "明星基金",
                    "重仓股",
                    "十年十倍股",
                    "大举增持"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "明星基金扎堆重仓股曝光，十年十倍股集中营，大举增持+超跌滞涨股仅6只",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "创新药/医疗器械/生物医药…八大医药指数，未来谁会更牛？",
            "features": {
                "keywords": [
                    "创新药",
                    "医疗器械",
                    "生物医药",
                    "医药指数"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "创新药/医疗器械/生物医药…八大医药指数，未来谁会更牛？",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "策略专题报告：“百年”行情电话会议纪要",
            "features": {
                "keywords": [
                    "策略专题",
                    "百年行情",
                    "电话会议"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "策略专题报告：“百年”行情电话会议纪要",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "诺威健康递表港交所，CRO行业格局生变？",
            "features": {
                "keywords": [
                    "诺威健康",
                    "港交所",
                    "CRO",
                    "行业格局"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "诺威健康递表港交所，CRO行业格局生变？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "从外资近期净流入和持仓风格变化角度：目前依然是核心资产牛市的延续而非普涨牛市",
            "features": {
                "keywords": [
                    "外资",
                    "净流入",
                    "持仓风格",
                    "核心资产",
                    "牛市"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "从外资近期净流入和持仓风格变化角度：目前依然是核心资产牛市的延续而非普涨牛市",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【医药生物*朱国广】CXO行业追踪报告：行业维持高景气，龙头公司空间广阔",
            "features": {
                "keywords": [
                    "医药生物",
                    "CXO",
                    "高景气",
                    "龙头公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药生物*朱国广】CXO行业追踪报告：行业维持高景气，龙头公司空间广阔",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "速递 | 剑指T细胞疗法治疗实体瘤两大障碍，新锐计划1.5亿美元IPO",
            "features": {
                "keywords": [
                    "T细胞疗法",
                    "实体瘤",
                    "新锐",
                    "IPO"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "速递 | 剑指T细胞疗法治疗实体瘤两大障碍，新锐计划1.5亿美元IPO",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]